Natural Beauty Bio-Technology Limited

Symbol: 0157.HK

HKSE

0.51

HKD

Markedspris i dag

-67.5714
P/E-forhold
-2.4025
PEG Ratio
1.02B
MRK Cap
0.00%
DIV Udbytte

Natural Beauty Bio-Technology Limited (0157-HK) Årsregnskaber

Q: Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er .

Download

Årlig Kvartalsvis

Lineær Log

På diagrammet kan du se standardtallene i dynamik for Natural Beauty Bio-Technology Limited (0157.HK). Virksomhedens omsætning viser gennemsnittet af NaN M, som er NaN % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er NaN M, som er NaN %. Den gennemsnitlige bruttofortjeneste er NaN %. Væksten i nettoindkomst for virksomheden sidste år er NaN %, hvilket svarer til NaN % % i gennemsnit for hele virksomhedens historie.,

Årlig Kvartalsvis

10Y 20Y 30Y 40Y

Balance

Når vi dykker ned i den skattemæssige udvikling for Natural Beauty Bio-Technology Limited, ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til . Et kig tilbage på det seneste år afslører en samlet aktivændring på NaN. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til NaN i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
balance-sheet.row.cash-and-short-term-investments	166.8	168.6	197.1	165.6	149.1	183.9	288.9	428.6	502.7	583.3	507.4	432.4	558.7	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	304.9	141.9
balance-sheet.row.short-term-investments	8.1	8	8.9	7.5	10.1	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	88.1	65.8
balance-sheet.row.net-receivables	85.4	80.9	119.9	118.9	103.7	71.3	98.2	73	41.2	50.8	83.7	55.1	0	44.7	0	93	0	164.9	141.2	124.6	130.7	0	0
balance-sheet.row.inventory	77.6	98.8	121	103.3	85.5	74.3	85.1	49.8	46.9	45	47	67.4	40.3	46.7	89.1	100.9	71	63.6	56.5	55.7	62.7	52.7	52.7
balance-sheet.row.other-current-assets	13.3	16.3	12.1	12	21.2	18.2	19.7	14.5	18.8	17	29.3	0.3	56.2	0.4	86.1	0.4	99.2	28	26.7	94.4	67.6	101.1	64.4
balance-sheet.row.total-current-assets	343	364.6	450	399.8	359.5	347.8	491.9	565.9	609.6	696.1	667.4	555.2	655.2	667.3	734.5	740.5	759	612.7	563.2	510.6	431.3	458.8	258.9
balance-sheet.row.property-plant-equipment-net	270.6	238.4	417.1	369.6	345	197.2	198.6	173.5	187.4	223.7	257.2	285.1	261.1	232.1	217.8	230.6	218	335.7	338.4	353.4	352.5	362.2	377.7
balance-sheet.row.goodwill	25.2	25.7	29.6	28.8	27.4	31.4	27.1	25.5	27	28.3	28.4	27.6	27.5	26.6	25.8	25.8	24.6	23.2	13.9	16.8	23.6	0	0
balance-sheet.row.intangible-assets	0	25.7	35.3	42.9	42.4	17.1	27.1	25.5	27	9.1	9.5	9.5	0	0	0	0	0	0	0.9	2.1	3.2	16.5	5.5
balance-sheet.row.goodwill-and-intangible-assets	25.2	51.4	64.9	71.7	69.8	48.5	27.1	25.5	27	28.3	28.4	37.1	27.5	26.6	25.8	25.8	24.6	23.2	14.8	18.9	26.8	16.5	5.5
balance-sheet.row.long-term-investments	217.7	228.7	9.5	8.8	7.9	11.2	7.9	8.9	10.2	250	284.6	-6.3	0	0	0	0	0	7.2	7.3	7.4	12.2	-76.9	-61.3
balance-sheet.row.tax-assets	24.4	25.2	25	19	12.9	5.2	217.8	190.2	0.6	2	1	0.7	0	0	3	9.2	7.5	9.4	4.7	4.7	9.8	0.8	1
balance-sheet.row.other-non-current-assets	1.6	-24.7	-29.3	-28.1	-27	-16.4	-225.7	-199.1	-10.8	-252	-285.6	12.3	14.8	14.9	18.2	20.2	23.2	9.5	9	5.2	8.7	100.1	65.8
balance-sheet.row.total-non-current-assets	539.5	518.9	487.1	441	408.6	245.7	225.7	199.1	214.4	252	285.6	328.8	303.4	273.6	264.8	285.7	273.3	385	374.3	389.6	410.1	402.7	388.6
balance-sheet.row.other-assets	0	0	0	0	0	85.4	60.3	57.2	64.6	29.7	29.1	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	882.6	883.5	937.2	840.8	768.1	679	777.9	822.2	888.6	977.7	982.1	884.1	958.6	940.9	999.3	1026.2	1032.3	997.7	937.5	900.2	841.4	861.5	647.5
balance-sheet.row.account-payables	20.7	9.8	15.2	26.1	26.2	20.5	21.5	20.9	14.9	18.6	21.3	18	135.8	126.1	93.8	106	90.3	70.2	82	55.5	53.7	82.8	135.2
balance-sheet.row.short-term-debt	171.7	119.4	94.8	59.5	22.1	-22.6	-6	-6.2	-6.6	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1
balance-sheet.row.tax-payables	3	7.5	19.3	9.7	4.7	9.7	18.4	24.3	28	43.8	26.7	12.7	12.8	9	14.5	41.2	4.7	27.6	15.8	20.7	13.5	11.3	20.8
balance-sheet.row.long-term-debt-total	3.5	6	9.5	2.3	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	0	24.1	24.8	13.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	71.2	104.8	114.4	107.2	82.5	105.3	94.1	141.8	128.7	172.6	159.6	108	19.3	19.6	24.8	51.6	14.5	37	24.2	29.9	18.8	16.6	20.8
balance-sheet.row.total-non-current-liabilities	24.7	35.3	41.3	24.9	42.1	1.3	11.5	4.8	12.3	12.6	13	10.1	15.3	12.6	11.9	12.3	11.9	11.3	10.9	10.2	8.4	7.6	6.8
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	11.1	18	24.8	13.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	308.1	286.1	279.2	229.5	200.3	127.1	127.1	167.5	156	203.8	193.8	136.1	170.4	158.3	130.5	169.8	116.7	118.5	117.2	95.6	80.8	107	164.9
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.1	200	0	0	0	0	0	0
balance-sheet.row.retained-earnings	39.1	54.6	85.4	50.3	42.8	189.1	259	314	355.5	361.3	365	169.8	0	0	0	0	0	0	0	0	0	118.2	105.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	263.6	271.1	294.7	277.1	241.3	255.1	284.9	220.4	256.8	128.8	139.5	-129	-104.1	-96.2	-117.3	-118.7	-141.8	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	71.6	71.6	77.6	83.6	83.6	-92.6	-93.3	-79.9	-79.9	83.6	83.6	507.1	691.9	678.4	785.2	768.6	851.4	878.7	813.5	795	750.4	615.9	348.7
balance-sheet.row.total-stockholders-equity	574.5	597.5	657.9	611.2	567.8	551.9	650.7	654.7	732.6	773.9	788.3	748.2	788	782.5	868.1	850	909.6	878.7	813.5	795	750.4	734.1	454.3
balance-sheet.row.total-liabilities-and-stockholders-equity	882.6	883.5	937.2	840.8	768.1	679	777.9	822.2	888.6	977.7	982.1	884.1	958.6	940.9	999.3	1026.2	1032.3	997.7	937.5	900.2	841.4	861.5	647.5
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	-0.2	0.2	0.1	0.7	6.4	6	0.4	6.8	9.7	10.2	20.3	28.3
balance-sheet.row.total-equity	574.5	597.5	657.9	611.2	567.8	551.9	650.7	654.7	732.6	773.9	788.3	748	788.2	782.6	868.8	856.4	915.7	879.2	820.3	804.6	760.6	754.5	482.6
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	225.8	236.7	18.4	16.3	18.1	2.9	7.9	8.9	10.2	250	284.6	-6.3	0	0	3.9	5.9	9.1	7.2	7.3	7.4	12.2	11.3	4.4
balance-sheet.row.total-debt	186.3	143.5	129.1	75	52.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1
balance-sheet.row.net-debt	27.5	-17.1	-59.1	-83.1	-86.1	-181	-288.9	-428.6	-502.7	-583.3	-507.4	-432.4	-558.7	-575.5	-559.3	-546.2	-588.7	-356.2	-338.7	-235.9	-170.3	-216.8	-74

Pengestrømsopgørelse

Det økonomiske landskab for Natural Beauty Bio-Technology Limited har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på NaN. Virksomheden udvidede for nylig sin aktiekapital ved at udstede NaN, hvilket markerer en forskel på NaN i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på NaN i rapporteringsvalutaen. Dette er en forskydning på NaN fra året før. I samme periode har virksomheden registreret NaN, NaN og NaN, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på NaN, med en forskel fra år til år på NaN. Desuden afsatte virksomheden NaN til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet NaN, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
cash-flows.row.net-income	-15.1	-30.5	35.3	7.8	21.9	26.3	105.4	148.4	136.8	71.5	58.3	155.3	173.6	75.8	186.8	308.5	208	122.8	81	62.7	54.1	66.5	71
cash-flows.row.depreciation-and-amortization	26.6	34.3	35	37.3	30.9	24.4	20.6	22.4	33.8	38.5	39.2	33.5	23.2	19.5	21.6	17.1	17.5	21.8	25.6	7.8	0	0	0
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	-12.2	-29.6	43.1	-38.6	-44.4	0	-61.1	-35.3	-50.8	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	9.3	1.1	1	-28	30.2	0	0.5	0.2	0.1	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	4.4	-0.1	-35.8	-28.1	-45	19.7	-65.7	-33.1	2.8	28.5	-44.1	-55.6	-3.5	86.4	-6.5	-14.9	110.1	-42.6	-45.9	18.5	-62.3	0	0
cash-flows.row.account-receivables	1	19.7	6.7	0.3	-42.7	25	-28.4	-29.9	9.1	31.7	-58	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	16.5	-1	-27	-24.7	-17.7	-5.3	-37.3	-3.3	-6.3	-3.3	13.9	-35.9	3.7	14.9	-3.2	-27	-7.4	-8.4	-9.2	7	-22.2	0	0
cash-flows.row.account-payables	-16.1	-23.3	-16.6	12.7	10.4	-11.7	-40.9	14.7	-35.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	3	4.4	1	-16.5	5	11.7	40.9	-14.7	35.8	0	0	-19.7	-7.2	71.5	-3.4	12.1	117.6	-34.1	-36.6	11.5	-40.1	0	0
cash-flows.row.other-non-cash-items	0.3	4.6	8.4	13.2	12.5	3.6	-39.1	-9.8	-42.7	25.5	53.9	-7	-8.7	-7.9	12.9	-6.3	-10.7	4.1	50.9	43.8	18.2	-17.8	40.2
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-69.1	-44.3	-38.1	-73.9	-76.4	-51.8	-32.3	-19	-14.4	-18.5	-22.6	-61.2	-50.7	-37.2	-17.1	-35.4	-53.8	-11.3	-24.9	-14.2	-11.8	-45.6	-74.4
cash-flows.row.acquisitions-net	0	0.3	8.2	20.1	0	-18.9	0	0	0	0	0	0	0	0	0	-3.5	1	0	0	0	-7.2	-0.9	-0.8
cash-flows.row.purchases-of-investments	0	0	-1.3	-25	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0	0	-9	3.2	12.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	0	0	9	25	0	9.6	0.3	30.8	-31.7	13.8	9.4	10.6	10.2	9.5	12.9	36.5	165.2	-10.5	74.7	-8.9	14.9	-19.6	-11.9
cash-flows.row.net-cash-used-for-investing-activites	-69.1	-44	-31.2	-50.6	-63.7	-61.1	-32	11.7	-46.1	-4.7	-13.1	-50.6	-40.5	-27.7	-4.2	-2.4	112.4	-21.8	49.8	-23.1	-4	-66.2	-87.1
cash-flows.row.debt-repayment	-54.3	-31.2	-27.2	-38.8	-24.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2.1	-0.2
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	-6	-6	0	0	-96.1	-99.7	-140.5	-142.3	-74.7	-25.6	-140.2	-160.2	-150.2	-137.1	-300	-185	-80.3	-61.3	-45	-52.3	-94.2	-39.8
cash-flows.row.other-financing-activites	104	55.3	47.6	68.6	45.1	0	-60.9	-50.1	0	0	0	-0.8	0	0	0	0.4	5.1	0	0	0	0	254	9.5
cash-flows.row.net-cash-used-provided-by-financing-activities	49.6	18.1	14.3	29.9	20.2	-96.1	-160.6	-190.6	-142.3	-74.7	-25.6	-140.9	-160.2	-150.2	-137.1	-299.7	-179.9	-80.3	-61.3	-45	-52.3	157.7	-30.5
cash-flows.row.effect-of-forex-changes-on-cash	1.4	-9.9	4.1	9.7	-3	-18	31.7	-23.2	-32.3	-9.9	5.4	6.2	13.1	20.1	0.3	-9.8	25.7	13.4	2.7	0.9	-0.3	0.5	-8.1
cash-flows.row.net-change-in-cash	-1.8	-27.6	30.1	19.2	-45.5	-130.7	-139.7	-74.1	-80.6	75.9	75	-125.9	-17.2	16.1	13.1	-42.5	232.5	17.5	102.8	65.7	-46.5	140.7	-14.5
cash-flows.row.cash-at-end-of-period	158.7	160.6	188.2	158.2	139	158.2	288.9	428.6	502.7	583.3	507.4	432.4	558.3	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	216.8	76.1
cash-flows.row.cash-at-beginning-of-period	160.6	188.2	158.2	139	184.5	288.9	428.6	502.7	583.3	507.4	432.4	558.3	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	216.8	76.1	90.6
cash-flows.row.operating-cash-flow	16.2	8.3	42.8	30.1	20.3	74	21.2	128	140.1	165.1	108.3	59.5	170.4	173.9	154.1	269.3	274.2	106.2	111.7	132.8	10.1	48.7	111.3
cash-flows.row.capital-expenditure	-69.1	-44.3	-38.1	-73.9	-76.4	-51.8	-32.3	-19	-14.4	-18.5	-22.6	-61.2	-50.7	-37.2	-17.1	-35.4	-53.8	-11.3	-24.9	-14.2	-11.8	-45.6	-74.4
cash-flows.row.free-cash-flow	-52.9	-36	4.7	-43.8	-56.1	22.2	-11.1	108.9	125.7	146.6	85.7	-1.7	119.6	136.7	137	233.9	220.4	94.9	86.8	118.6	-1.7	3	36.8

Resultatopgørelse række

Natural Beauty Bio-Technology Limiteds omsætning oplevede en ændring på NaN% sammenlignet med den foregående periode. Bruttofortjenesten for 0157.HK rapporteres til at være NaN. Virksomhedens driftsomkostninger er NaN og viser en ændring på NaN% fra sidste år. Udgifterne til afskrivninger er NaN, hvilket er en ændring på NaN% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være NaN, hvilket viser en NaN% ændring fra år til år. Salgs- og marketingomkostninger er NaN, hvilket er en ændring på NaN% sammenlignet med året før. EBITDA baseret på de seneste tal er NaN, hvilket repræsenterer en NaN% vækst i forhold til året før. Driftsindtægterne er NaN, som viser en ændring på NaN% sammenlignet med året før. Ændringen i nettoindkomsten er NaN%. Nettoindkomsten for det sidste år var NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
income-statement-row.row.total-revenue	336	335.9	487.8	410.7	438.4	369.5	399.6	475.2	506.9	505.8	439.4	483.4	591.3	485.4	538.1	592.7	450.1	363.7	357.9	358.1	320.1	306.3	254.6
income-statement-row.row.cost-of-revenue	157.3	170.6	206	193.4	190.1	146.7	94.5	122.4	109.4	117	106.3	103.6	122.2	130	122.9	86.1	77.6	68.7	73.3	82.3	61.2	86.8	63.8
income-statement-row.row.gross-profit	178.7	165.3	281.8	217.2	248.3	222.9	305.1	352.9	397.5	388.8	333.1	379.8	469.1	355.4	415.2	506.6	372.6	295	284.6	275.9	258.9	219.5	190.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	5.8	7	4.5	3.5	-0.4	-1	-6.1	-2.4	8.5	-26.3	0.2	-4.6	-10.2	7.7	1.4	-42.2	-28.2	108.3	145.9	112.6	125.3	103.6	76.2
income-statement-row.row.operating-expenses	182.5	188.7	237	212.9	209.2	186.7	162.7	162.8	238.8	286	259.4	227.7	295.5	279.5	230.8	198.1	164.3	167.7	207.8	176.5	194.9	162.8	117.2
income-statement-row.row.cost-and-expenses	339.8	359.3	443.1	406.4	399.3	333.4	257.2	285.2	348.2	403	365.7	331.3	417.6	409.5	353.7	284.2	241.8	236.4	281.1	258.7	256.1	249.6	181
income-statement-row.row.interest-income	1.5	1.7	2.1	1.7	1.6	3	4.3	6.2	11.7	13.5	9.3	7	0	0	2.4	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	8.1	6.2	4.9	2.7	1.3	0	0	0	0	0	0	-3.3	0	-0.6	-8.1	0.1	0.4	-47.1	-43.1	0.3	-0.7	-3.3	-3.6
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-8.1	-0.1	3.7	4.7	-2.1	1.8	9	33.3	19.7	-10.2	19.9	0	0	0	0	0	-0.3	47.1	43.1	-0.3	0	2	2.3
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	5.8	7	4.5	3.5	-0.4	-1	-6.1	-2.4	8.5	-26.3	0.2	-4.6	-10.2	7.7	1.4	-42.2	-28.2	108.3	145.9	112.6	125.3	103.6	76.2
income-statement-row.row.total-operating-expenses	-8.1	-0.1	3.7	4.7	-2.1	1.8	9	33.3	19.7	-10.2	19.9	0	0	0	0	0	-0.3	47.1	43.1	-0.3	0	2	2.3
income-statement-row.row.interest-expense	8.1	6.2	4.9	2.7	1.3	0	0	0	0	0	0	-3.3	0	-0.6	-8.1	0.1	0.4	-47.1	-43.1	0.3	-0.7	-3.3	-3.6
income-statement-row.row.depreciation-and-amortization	26.6	34.3	35	37.3	30.9	24.4	20.6	22.4	33.8	38.5	39.2	33.5	23.2	19.5	21.6	17.1	17.5	21.8	25.6	7.8	-19.5	-28.4	-6.4
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-3.8	-23.4	44.7	4.3	39.1	37.3	137.8	162.9	150.7	126.4	63.1	155.3	173.6	75.8	186.8	308.5	208.3	127.3	76.8	99.4	83.5	85.1	79.9
income-statement-row.row.income-before-tax	-11.9	-23.5	48.5	9	37	39.2	146.7	196.2	170.4	116.3	83.1	155.3	173.6	75.8	186.8	308.5	208	174.5	119.8	99.1	83.5	87	82.2
income-statement-row.row.income-tax-expense	3.2	6.9	13.2	1.2	15.1	12.9	41.4	47.8	33.6	44.8	24.6	36.1	58.5	45.1	42.8	69.9	29.2	51.6	38.8	36.3	30.1	21.9	12.5
income-statement-row.row.net-income	-15.1	-30.5	35.3	7.8	21.9	26.3	105.4	148.4	136.8	71.5	58.3	119.3	115.1	31.3	149.6	238.5	178.7	122.8	81	62.7	54.1	66.5	71